DICER1 (Dicer 1, Ribonuclease III) is a fundamental gene encoding an essential endoribonuclease for microRNA (miRNA) biogenesis. In the nervous system, DICER1 plays critical roles in neuronal development, synaptic plasticity, and survival. Dysregulation of DICER1 has been strongly implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders.
| DICER1 |
| Gene Symbol | DICER1 |
| Full Name | Dicer 1, Ribonuclease III |
| Chromosome | 14q32.13 |
| NCBI Gene ID | 27105 |
| OMIM | 604310 |
| Ensembl ID | ENSG00000100697 |
| UniProt ID | Q9UPY3 |
| Associated Diseases | Dicer1 Syndrome, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Spinocerebellar Ataxia |
DICER1 encodes a conserved endoribonuclease essential for the biogenesis of microRNAs (miRNAs). As a member of the RNase III family, DICER1 processes precursor miRNAs (pre-miRNAs) into mature ~22-nucleotide miRNAs, which regulate gene expression post-transcriptionally. In neurons, DICER1 and the miRNA pathway are critical for synaptic plasticity, neuronal development, axonal integrity, and survival.
Dysfunction of DICER1 is strongly linked to neurodegenerative diseases. Studies have shown that DICER1 protein and mRNA are reduced in the hippocampi of Alzheimer's disease mouse models, and this reduction is mediated by amyloid-beta (Aβ42)-induced repression of the Nrf2-ARE antioxidant signaling pathway. Loss of DICER1 function leads to impaired miRNA processing, resulting in widespread changes in gene expression that compromise neuronal health.
The DICER1 gene spans approximately 65 kb on chromosome 14q32.13 and consists of 25 exons. The encoded protein is approximately 219 kDa and contains multiple functional domains:
- N-terminal DExD/H-box helicase domain: Involved in RNA binding and unwinding
- DUF283 domain: Platform for protein-protein interactions
- PAZ domain: Binds the 3' overhang of pre-miRNA substrates
- Two RNase III domains (RNase IIIa and IIIb): Form a heterodimer that cleaves the pre-miRNA hairpin
- Double-stranded RNA binding domain (dsRBD): Recognizes double-stranded RNA structures
DICER1 is the central enzyme in the canonical miRNA biogenesis pathway:
- Primary miRNA (pri-miRNA) processing: The microprocessor complex (DGCR8/Pasha and Drosha) cleaves pri-miRNA in the nucleus to generate ~70-nucleotide pre-miRNA
- Nuclear export: Exportin-5 transports pre-miRNA to the cytoplasm
- Pre-miRNA processing: DICER1, in complex with TRBP (TAR RNA-binding protein), cleaves the pre-miRNA hairpin to produce ~22-nucleotide mature miRNA duplex
- MiRNA loading: One strand of the duplex is loaded into the RNA-induced silencing complex (RISC), with AGO2 as the core component
In neurons, DICER1 and miRNAs regulate:
- Synaptic plasticity: Activity-dependent miRNA expression modulates synaptic strength and structure
- Axonal growth and guidance: Local miRNA processing in axons regulates axonal regeneration
- Neuronal survival: Anti-apoptotic and pro-survival gene regulation via miRNA pathways
- Dendritic spine morphology: miRNA-mediated control of cytoskeletal proteins
- Neurotransmission: Regulation of neurotransmitter receptor expression and function
DICER1 is ubiquitously expressed but shows particularly high expression in the brain:
- Brain regions: Highest expression in hippocampus, cerebral cortex, cerebellum, and substantia nigra — regions prominently affected in neurodegenerative diseases
- Cellular localization: Expressed in both cytoplasm and nucleus of neurons
- Subcellular distribution: Localized to dendritic compartments, enabling local miRNA processing at synapses
| Disease |
Role of DICER1 |
Key Evidence |
| Alzheimer's Disease |
Significantly reduced |
DICER1 mRNA and protein decreased in AD mouse models; Aβ represses DICER1 via Nrf2 pathway |
| Parkinson's Disease |
Dysregulated |
Loss of DICER1 impairs neuronal survival; linked to alpha-synuclein pathology |
| Amyotrophic Lateral Sclerosis |
Loss-of-function mutations |
Mutations (E1592K, R1778H) disrupt miRNA processing; leads to motor neuron degeneration |
| Spinocerebellar Ataxia |
Impaired function |
Reduced DICER1 contributes to cerebellar degeneration |
| Dicer1 Syndrome |
Tumor suppressor |
Heterozygous loss-of-function causes predisposition to various tumors |
In Alzheimer's disease, several mechanisms link DICER1 dysfunction to pathology:
- Aβ-induced repression: Chronic exposure to amyloid-beta peptide reduces DICER1 expression through attenuation of Nrf2-ARE signaling
- Phosphorylation dysregulation: Short-term Aβ exposure alters DICER1 phosphorylation via JNK, ERK, and calcineurin pathways
- Oxidative stress: DICER1 knockdown induces oxidative stress, mitochondrial dysfunction, and apoptosis in neurons
- Synaptic impairment: Loss of DICER1 disrupts synaptic plasticity through dysregulated miRNA expression
- Therapeutic potential: DICER1 overexpression has been shown to rescue Aβ-induced neurite deficits and improve spatial learning in AD mouse models
ALS-associated DICER1 mutations (E1592K, R1778H) disrupt miRNA biogenesis:
- Impaired processing of miRNAs critical for motor neuron survival
- Dysregulation of genes controlling RNA metabolism and stress responses
- Contribution to RNA toxicity mechanisms in ALS pathogenesis
DICER1 dysfunction in PD:
- Contributes to dopaminergic neuron vulnerability
- Links to alpha-synuclein pathology through miRNA regulatory networks
- Impairs cellular stress response mechanisms
- AAV-mediated DICER1 delivery: Restoring DICER1 expression using adeno-associated viral vectors
- Promoting Nrf2 signaling: Indirectly upregulate DICER1 through Nrf2-ARE pathway activation
- miRNA replacement therapy: Deliver specific miRNAs downstream of DICER1
- Anti-miRNA oligonucleotides: Block toxic miRNA species
- Antioxidant therapy: Nrf2 activators may restore DICER1 expression
- Amyloid-targeting approaches: Reducing Aβ burden indirectly preserves DICER1 function
- Phosphorylation modulators: Targeting kinases/phosphatases that regulate DICER1
- Conditional neuronal DICER1 knockout: Mice with neuron-specific DICER1 loss exhibit neurodegeneration, ataxia, and premature death
- APP/PSEN1 AD model: Shows reduced DICER1 in hippocampus, replicating human AD pathology
- Dicer1 conditional knockout in dopaminergic neurons: Progressive loss of dopaminergic neurons, modeling PD
The study of Dicer1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wang et al., Brain (2020)
- Wang et al., Journal of Neurochemistry (2021)
- He & Wang, Journal of Molecular Neuroscience (2020)
- Gasparini & Sanna, Advances in Experimental Medicine and Biology (2020)
- Bu & Li, Neurochemical Research (2020)